# Huons Co., Ltd. clinical trials: 29 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 29 trials with Huons Co., Ltd. as lead sponsor, 5 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Huons Co., Ltd.: 29 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/huons-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 29
- Recruiting or not yet: 5
- Read on: November 19, 2026

## Trials

The 25 newest of 29, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 25, 2026 | NCT07784621 | A Phase 1 Clinical Trial to Evaluate the Safety and the Pharmacokinetic Drug-Drug Interaction Between HUC2A-752-A and HUC2A-752-B in... | Huons Co., Ltd. | Phase 1 | Not yet recruiting | Hypertension | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784621) |
| August 25, 2026 | NCT07784608 | A Clinical Trial to Evaluate the Drug-drug Interactions of Co-administered 'HUC2-744-A' and 'HUC2-744-B' in Healthy Adult Volunteers | Huons Co., Ltd. | Phase 1 | Not yet recruiting | Drug-drug Interactions | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784608) |
| June 18, 2026 | NCT07656688 | Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease | Huons Co., Ltd. | Phase 2 | Recruiting | Dry Eye Disease (DED) | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07656688) |
| January 13, 2026 | NCT07337174 | Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult... | Huons Co., Ltd. | Phase 1 | Not yet recruiting | Obesity | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07337174) |
| January 13, 2026 | NCT07335211 | Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension | Huons Co., Ltd. | Phase 3 | Recruiting | Primary Open Angle Glaucoma (POAG), Ocular Hypertension | 206 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07335211) |
| October 1, 2024 | NCT06618079 | Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B | Huons Co., Ltd. | Phase 1 | Unknown | Hypertension | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06618079) |
| August 13, 2024 | NCT06552182 | Phase 1 Study in Diabetes Mellitus(Fasting) | Huons Co., Ltd. | Phase 1 | Completed | Diabetes, Diabetes Mellitus | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06552182) |
| August 13, 2024 | NCT06551740 | Phase 1 Study in Diabetes Mellitus(Fed) | Huons Co., Ltd. | Phase 1 | Completed | Diabetes, Diabete Mellitus | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06551740) |
| April 29, 2024 | NCT06388070 | To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome | Huons Co., Ltd. | Phase 3 | Completed | Dry Eye Syndromes | 297 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06388070) |
| February 16, 2024 | NCT06263998 | Clinical Study for the Evaluation of Safety and Tolerability of NCP112 Eye Drops | Huons Co., Ltd. | Phase 1 | Unknown | Xerophthalmia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06263998) |
| February 24, 2023 | NCT05743764 | HU007 in Patients with Dry Eye Syndrome | Huons Co., Ltd. | Phase 3 | Completed | Dry Eye Disease | 328 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05743764) |
| March 28, 2022 | NCT05298449 | Phase 2 of HU-045 in Glabellar Lines | Huons Co., Ltd. | Phase 2 | Completed | Glabellar Lines | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05298449) |
| March 22, 2022 | NCT05289921 | To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb | Huons Co., Ltd. | Phase 3 | Completed | Post Stroke Upper Limb Spasticity | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05289921) |
| June 4, 2020 | NCT04415346 | A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity | Huons Co., Ltd. | Phase 1 | Unknown | Post Stroke Upper Limb Spasticity | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04415346) |
| May 12, 2020 | NCT04384991 | HU007 Eye Drops in Patients With Dry Eye Syndrome | Huons Co., Ltd. | Phase 3 | Completed | Dry Eye Syndromes | 216 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04384991) |
| January 13, 2020 | NCT04224649 | To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds | Huons Co., Ltd. | Not applicable | Unknown | Nasolabial FOLD | 67 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04224649) |
| September 9, 2019 | NCT04081402 | A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet... | Huons Co., Ltd. | Phase 3 | Unknown | Crow's Feet Lines | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04081402) |
| April 12, 2018 | NCT03495739 | Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male Volunteers | Huons Co., Ltd. | Phase 1 | Unknown | Healthy | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03495739) |
| March 23, 2018 | NCT03475719 | A Clinical Trial to Evaluate the Safety and Pharmacokinetic | Huons Co., Ltd. | Phase 1 | Unknown | Osteoporosis, Postmenopausal | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03475719) |
| March 12, 2018 | NCT03461575 | Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome | Huons Co., Ltd. | Phase 3 | Completed | Dry Eye Syndrome | 209 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03461575) |
| February 22, 2018 | NCT03440671 | The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines | Huons Co., Ltd. | Phase 3 | Unknown | Glabellar Frown Lines | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03440671) |
| November 11, 2016 | NCT02961673 | The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines | Huons Co., Ltd. | Phase 1/2 | Completed | Glabellar Lines | 57 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02961673) |
| September 28, 2016 | NCT02917512 | Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome | Huons Co., Ltd. | Phase 2 | Completed | Dry Eye Syndrome | 114 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02917512) |
| September 15, 2016 | NCT02902523 | Clinical Trial to Assess the Safety and Pharmacokinetics of HUG116 Tablet and Viread® Tablet in Healthy Male Volunteers | Huons Co., Ltd. | Phase 1 | Completed | Healthy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02902523) |
| September 8, 2016 | NCT02893098 | A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee | Huons Co., Ltd. | Phase 3 | Completed | Osteoarthritis of Knee | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02893098) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 12 |
| Phase 1/2 | 1 |
| Phase 2 | 4 |
| Phase 3 | 10 |
| Phase 4 | 1 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 16 |
| Unknown | 8 |
| Not yet recruiting | 3 |
| Recruiting | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Dry Eye Syndromes | 7 |
| Hypertension | 3 |
| Diabetes Mellitus | 2 |
| Obesity | 1 |
| Xerophthalmia | 1 |
| Glaucoma, Open-Angle | 1 |
| Ocular Hypertension | 1 |
| Osteoarthritis, Knee | 1 |
| Osteoporosis, Postmenopausal | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B quarry companies in the United States](https://specstream.ai/data/businesses/b2b-quarry-companies/united-states)
- [Credit and debt counseling services in the United States](https://specstream.ai/data/businesses/credit-and-debt-counseling-services/united-states)
- [Geological services in the United States](https://specstream.ai/data/businesses/geological-services/united-states)
- [Marketing agencies in the United States](https://specstream.ai/data/businesses/marketing-agencies/united-states)
- [Process servers in the United States](https://specstream.ai/data/businesses/process-servers/united-states)
- [Tobacco companies in the United States](https://specstream.ai/data/businesses/tobacco-companies/united-states)
